• inquiry@market.us
  • +1 718 618 4351 (International)
  • +91 78878 22626 (Asia)
  • About Us
  • Contact Us
menu One Stop Shop For Reports One Stop Shop For Reports
search more_vert
  • All Reports
  • All Sectors
  • Infographics
  • News Media
    • United States
    • United Kingdom
    • Asia Pacific
  • Who Trust Us
  • Datafeature
Home / Optathalmic Viscosurgical Devices Market
  • Home / Optathalmic Viscosurgical Devices Market

Optathalmic Viscosurgical Devices Market By Product Type (Dispersive, Cohesive, Combined), Based on End-User (Hospitals & Clinics, Ophthalmic Clinics, Others), By Application (Canaloplasty, Refractive Surgery, Keratoplasty,Others) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022-2032

  • Overview
  • Table of Contents
  • Major Market Players
  • Inquiry Before Buying
  • account_circleAbout Me
    • 78037
    • US $6,000
      US $3,999
    • US $8,000
      US $5,999
    • US $10,000
      US $6,999
    Buy Now

    Overview:

    An Ophthalmic Viscosurgical Device (OVD), also known as a viscoelastic agent or viscoelastic solution, is used to make cataract surgical procedures more successful. During phaco surgery, these solutions are used to both create and maintain space in the anterior chamber of the eye. OVDs are also used during Intraocular Lens (IOL) implantation, to protect the corneal endothelium, and to line surgical instruments. OVDs are unique in that they possess both solid and fluid characteristics. The surgical applications of the different OVDs are mainly determined by their physical properties, which are a consequence of the length of their molecular chain and the interactions both within the chains and between the chains and the ocular tissue.

    Optathalmic Viscosurgical Devices Value Analysis

    Detailed Segmentation:

    The global ophthalmic viscosurgical devices market is segmented on the basis of - Product Type, End-User, and Region. A detailed segmental description is listed below:

    Request Covid - 19 Impact

    Based on Product Type

    • Dispersive
    • Cohesive
    • Combined

    Based On Application:

    • Cataract Surgery
    • Vitreoretinal Surgery
    • Canaloplasty
    • Refractive Surgery
    • Keratoplasty
    • Others

    Based on End-User

    • Hospitals & Clinics
    • Ophthalmic Clinics
    • Others

    Market Dynamics:

    Drivers for the Global Optathalmic Viscosurgical Devices Market

    In cataract surgery, the steady adoption of ophthalmic viscosurgical devices can be attributed to an increasing number of specific patient groups as well as an increased awareness of various eye diseases. In addition, it is projected that this global market will index healthy economic growth in the future. These devices aid in the preservation of the anterior chamber space and prevent the loss of corneal endothelial cells during ocular surgical procedures. Therefore, this device contributes to the improvement of surgical procedures. In addition, a decrease in intraoperative surgical complications associated with the use of this device as well as various technological advances is resulting in better and more successful surgical results.

    According to Eurostat, in 2017, around 5 million cataract surgeries were performed in Europe. With such a high number of surgeries performed, and due to several benefits associated with the use of this device, the further adoption of ophthalmic viscosurgical devices is expected to augment this industry’s revenue growth trajectory.

    Restraints for the Global Optathalmic Viscosurgical Devices Market

    With the onset of the COVID-19 pandemic, the market for ophthalmic visco-surgical devices, just like a majority of markets, has been negatively affected. Initially, the SARS-CoV-2 outbreak disrupted supply chains and resulted in imposed restrictions on trade and movement of goods, thereby affecting this market. For example, the US declared a national emergency and banned all elective diagnostic and surgical procedures in outpatient and hospital settings.

    Competitive Landscape:

    Key players in this market are –

    • Alcon
    • Amring Pharmaceuticals
    • Bausch & Lomb Incorporated
    • Bohus Biotech AB
    • Carl Zeiss Meditec AG
    • CIMA Technology Inc.
    • Johnson & Johnson Surgical Vision Inc.
    • Maxigen Biotech Inc.
    • Precision Lens
    • Rayner Intraocular Lenses Ltd. among others.

    Optathalmic Viscosurgical Devices Company Analysis

    These key industry players are now focusing on mergers, partnerships, acquisitions, product developments, and collaboration strategies, in order to sustain their respective competitive edges.

    Key Developments:

    In April 2021, Bausch & Lomb Incorporated received U.S. FDA approval for ClearVisc. ClearVisc is a dispersive ophthalmic viscosurgical device used in ophthalmic surgery. This strategic move will strengthen the company’s market position and expand its existing portfolio in the ophthalmic viscosurgical devices segment.

    In October 2019, Carl Zeiss Meditec announced the acquisition of IanTECH Inc., a firm emphasized the manufacturing of products for micro-interventional cataract surgical procedures. This acquisition was intended to improve the company’s product portfolio of surgical ophthalmology solutions and further position the firm as a global provider in the field of ophthalmology.

    Optathalmic Viscosurgical Devices Market

    add_shopping_cartBuy Now get_appDownload Sample
    keyboard_arrow_up
  • account_circleAbout Me
    • 78037
    • US $6,000
      US $3,999
    • US $8,000
      US $5,999
    • US $10,000
      US $6,999
    Buy Now
  • ondemand_videoVideos
    • 78037
    • US $6,000
      US $3,999
    • US $8,000
      US $5,999
    • US $10,000
      US $6,999
    Buy Now
    • Alcon
    • Amring Pharmaceuticals
    • Bausch & Lomb Incorporated
    • Bohus Biotech AB
    • Carl Zeiss Meditec AG
    • CIMA Technology Inc.
    • Johnson & Johnson Surgical Vision Inc.
    • Maxigen Biotech Inc.
    • Precision Lens
    • Rayner Intraocular Lenses Ltd. among others.
  • settingsSettings

Our Clients

Request for Sample


  • 78037
  • US $6,000
    US $3,999
  • US $8,000
    US $5,999
  • US $10,000
    US $6,999
Buy Now
  • location_on420 Lexington Avenue, Suite 300 New York City, NY 10170,
    United States
  • phone+1 718 618 4351 (International)
  • phone+91 78878 22626 (Asia)
  • emailinquiry@market.us

Find Help

  • Contact Us
  • How to Order

Legal

  • Privacy Policy
  • Refund Policy
  • Frequently Asked Questions
  • Terms and Conditions

Explore

  • About Us
  • All Reports
  • All Sectors
  • Infographics
  • Statistics and Facts

Secured Payment Options

© 2022 Market.Us. All Rights Reserved.